PME April 2026

Explore the April issue of PME, featuring the $150bn GLP-1 weight loss market and the race for oral obesity medications. This edition covers critical challenges in tuberculosis treatment adherence and the groundbreaking use of CAR-T cell therapies for lupus, an autoimmune condition disproportionately affecting women and ethnic minority groups. Stay ahead with the latest in pharmaceutical innovation and clinical breakthroughs.

Explore the April issue of PME: The $150bn GLP-1 weight loss market and the shift to oral meds, challenges in tuberculosis treatment adherence, and the potential of CAR-T cell therapies for lupus and autoimmune diseases. Read the latest pharma insights.

April 2026 - Pharmaceutical Market Europe

Pharmaceutical industry news, articles, jobs, reports, advice and services

Pharmaceutical Market Europe

PME – Pharmaceutical Market Europe is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

Creating a bridge between weight loss drugs and long-term behaviour change

Tuberculosis – searching for a cure while fighting drug resistance

The challenges of finding a cure for lupus and related autoimmune conditions